Company / Current Liabilities per Share
Vaxcyte, Inc. Current Liabilities per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.51
FY2025
5-year range
$0.55 / $1.51
FY2021-FY2025
Trend
+31.6%
vs FY2024
Sector context
#87 of 210
Health Care
What the data says
At $1.51, Vaxcyte, Inc.'s current liabilities per share ranks #124 of 210 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 7 years, ranging from $0.55 in FY2021 to $2.91 in FY2019.
Based on SEC 10-K filings.
1.51 in FY2025 with a 5-year CAGR of -1.0%.
Remained stable around $1.51 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +34.3%
- 5-Year CAGR
- -1.0%
- 10-Year CAGR
- -
Sector benchmark
#124 of 210 in Health CareTop 59% of 210This company $1.51 Sector average $23.79
▼
-93.6% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 31.6% year-over-year.
- Ranks #87 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2019.
- Lowest current liabilities per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.94 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.51 | +31.6% |
| FY2024 | $1.15 | -23.2% |
| FY2023 | $1.50 | +139.5% |
| FY2022 | $0.62 | +12.9% |
| FY2021 | $0.55 | -65.1% |
| FY2020 | $1.59 | -45.5% |
| FY2019 | $2.91 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026